INCY

Incyte Corporation · Healthcare · Biotechnology
$123.47
-0.03 (-0.02%)
Mkt Cap: 25.03B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield7.0%
Dividend YieldN/A
Market Cap25.03B
Volume1.19M
Recent News
Global Vitiligo Foundation Applauds Incyte's “Moments of Clarity” Campaign for Elevating Patient Voices and Advancing Vitiligo Awareness
businesswire.com · 2026-08-17
Incyte Sales Growth Drives Share Price Gains
fxempire.com · 2026-08-12
Cetera Investment Advisers Has $2.40 Million Position in Incyte Corporation $INCY
defenseworld.net · 2026-08-09
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com · 2026-08-07
REGN or INCY: Which Is the Better Value Stock Right Now?
zacks.com · 2026-08-05
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
prnewswire.com · 2026-08-02

Unlock the Full Deep Scan

9 AI agents analyze INCY across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →